308
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia?

, &
Pages 2401-2405 | Received 30 Aug 2011, Accepted 21 May 2012, Published online: 25 Jun 2012

References

  • Ghosh B, Mittal S, Kumar S, Dadhwal V. Prediction of perinatal asphyxia with nucleated red blood cells in cord blood of newborns. Int J Gynaecol Obstet 2003;81:267–271.
  • Azra Haider B, Bhutta ZA. Birth asphyxia in developing countries: current status and public health implications. Curr Probl Pediatr Adolesc Health Care 2006;36:178–188.
  • Saving Newborn Lives. The state of the world’s newborn: a report from saving newborn lives. Washington DC: Save the children: 2001; 1–44.
  • Immanuel S, Sanjaya AI. Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome. Acta Med Indones 2006;38:92–96.
  • Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006;8:27–31.
  • Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311–315.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P. Current role of ischemia-modified albumin in routine clinical practice. Biomarkers 2010;15:655–662.
  • Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008;49:260–266.
  • Alonso-Spilsbury M, Mota-Rojas D, Villanueva-García D, Martínez-Burnes J, Orozco H, Ramírez-Necoechea R, Mayagoitia AL, Trujillo ME. Perinatal asphyxia pathophysiology in pig and human: a review. Anim Reprod Sci 2005;90:1–30.
  • Levene MI, deVries LS. Hypoxic-ischemic encephalopathy. In: Fanaroff & Martin’s Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 9th ed, Martin RJ, Fanaroff AA, Walsh MC (Eds), St.Louis: Elsevier, 2011. p. 952.
  • Alonso-Spilsbury M, Mota-Rojas D, Villanueva-García D, Martínez-Burnes J, Orozco H, Ramírez-Necoechea R, Mayagoitia AL, Trujillo ME. Perinatal asphyxia pathophysiology in pig and human: a review. Anim Reprod Sci. 2005; 90:1–30.
  • da Silva S, Hennebert N, Denis R, Wayenberg JL. Clinical value of a single postnatal lactate measurement after intrapartum asphyxia. Acta Paediatr 2000;89:320–323.
  • Rajakumar PS, Bhat BV, Sridhar MG, Balachander J, Konar BC, Narayanan P, Chetan G. Cardiac enzyme levels in myocardial dysfunction in newborns with perinatal asphyxia. Indian J Pediatr 2008;75:1223–1225.
  • Doroszko A, Polewicz D, Cadete VJ, Sawicka J, Jones M, Szczesna-Cordary D, Cheung PY, Sawicki G. Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction. Shock 2010;34:592–600.
  • Kumar A, Ramakrishna SV, Basu S, Rao GR. Oxidative stress in perinatal asphyxia. Pediatr Neurol 2008;38:181–185.
  • Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–160.
  • Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009;88:479–482.
  • Dundar ZD, Cander B, Gul M, Karabulut KU, Girisgin S. Serum ischemia-modified albumin levels in an experimental acute mesenteric ischemia model. Acad Emerg Med 2010;17:1233–1238.
  • Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007;22:2029–2032.
  • Uygun M, Yilmaz S, Pekdemir M, Duman C, Gürbüz YS. The diagnostic value of ischemia-modified albumin in a rat model of acute mesenteric ischemia. Acad Emerg Med 2011;18:355–359.
  • Kotani K, Kimura S, Gugliucci A. Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease. J Physiol Biochem 2011;67:437–441.
  • Guven S, Karahan SC, Kandemir O, Ucar U, Cora AO, Bozkaya H. Occult inflammation and/or ischemia may be responsible for the false positivity of biochemical Down syndrome screening test. J Perinat Med 2010;38:367–371.
  • Özdemir S, Kiyici A, Balci O, Göktepe H, Çiçekler H, Çelik Ç. Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester. Eur J Obstet Gynecol Reprod Biol 2011;155:209–212.
  • Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod 2008;23:803–806.
  • Ustün Y, Engin-Ustün Y, Oztürk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011;24:418–421.
  • Gafsou B, Lefèvre G, Hennache B, Houfflin Debarge V, Ducloy-Bouthors AS. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy 2010;29:101–111.
  • Iacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, Hassiakos D, Malamitsi-Puchner A. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081.
  • van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:159–167.
  • Songül Sahinli A, Marakoglu K, Kiyici A. Evaluation of the levels of oxidative stress factors and ischemia modified albumin in the cord blood of smoker and non-smoker pregnant women. J Matern Fetal Neonatal Med 2011 [Epub ahead of print].
  • Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.